S&P Global Inc. (NYSE:SPGI) Receives Average Recommendation of “Buy” from Analysts
Chronological Source Flow
Back
AI Fusion Summary
ResMed Inc. receives a consensus recommendation of Moderate Buy from fourteen covering brokerages, with four holding, nine buying, and one strong buying; the average one‑year target price is $299.27. S&P Global Inc. is rated Buy by eighteen analysts, seventeen buying and one strong buying, with an average 12‑month target price reported.
Comments